Impact of symptom variability on clinical outcomes in COPD: analysis of a longitudinal cohort

References

• Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2019. Available from: http://goldcopd.org. Accessed April 5, 2019.
   Google Scholar
• Kessler R, Partridge MR, Miravitlles M, et al. Symptom variability in patients with severe COPD: a pan-European cross-sectional study. Eur Respir J. 2011;37(2):264–272. doi:10.1183/09031936.0005111021115606
   PubMed Web of Science ®Google Scholar
• Espinosa de los Monteros MJ, Peña C, Soto Hurtado EJ, Jareño J, Miravitlles M. Variability of respiratory symptoms in severe COPD. Arch Bronconeumol. 2012;48(1):3–7. doi:10.1016/j.arbr.2011.07.00621944843
   PubMed Web of Science ®Google Scholar
• Kim YJ, Lee BK, Jung CY, et al. Patient’s perception of symptoms related to morning activity in chronic obstructive pulmonary disease: the SYMBOL Study. Korean J Intern Med. 2012;27(4):426–435. doi:10.3904/kjim.2012.27.4.42623269884
   PubMed Web of Science ®Google Scholar
• Partridge MR, Karlsson N, Small IR. Patient insight into the impact of chronic obstructive pulmonary disease in the morning: an internet survey. Curr Med Res Opin. 2009;25(8):2043–2048. doi:10.1185/0300799090310300619569976
   PubMed Web of Science ®Google Scholar
• Tsiligianni I, Metting E, van der Molen T, Chavannes N, Kocks J. Morning and night symptoms in primary care COPD patients: a cross-sectional and longitudinal study. An UNLOCK study from the IPCRG. NPJ Prim Care Respir Med. 2016;26:16040. doi:10.1038/npjpcrm.2016.4027442618
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Worth H, JJS C, et al. Observational study to characterise 24-hour COPD symptoms and their relationship with patient-reported outcomes: results from the ASSESS study. Respir Res. 2014;15(1):122. doi:10.1186/s12931-014-0122-125331383
   PubMed Web of Science ®Google Scholar
• van Buul AR, Kasteleyn MJ, Chavannes NH, Taube C. Association between morning symptoms and physical activity in COPD: a systematic review. Eur Respir Rev. 2017;26(143):160033. doi:10.1183/16000617.0033-201628049127
   PubMed Web of Science ®Google Scholar
• Lopez-Campos JL, Calero C, Quintana-Gallego E. Symptom variability in COPD: a narrative review. Int J Chron Obstruct Pulmon Dis. 2013;8:231–238. doi:10.2147/COPD.S4286623687444
   PubMed Web of Science ®Google Scholar
• Timmins SC, Coatsworth N, Palnitkar G, et al. Day-to-day variability of oscillatory impedance and spirometry in asthma and COPD. Respir Physiol Neurobiol. 2013;185(2):416–424. doi:10.1016/j.resp.2012.08.01722960661
   PubMed Web of Science ®Google Scholar
• Rothwell PM, Howard SC, Dolan E, et al. Effects of β blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke. Lancet Neurol. 2010;9(5):469–480. doi:10.1016/S1474-4422(10)70066-120227347
   PubMed Web of Science ®Google Scholar
• Sunwoo JS, Yang TW, Kim DY, et al. Association of blood pressure variability with orthostatic intolerance symptoms. PLoS One. 2017;12(6):e0179132. doi:10.1371/journal.pone.017913228591231
   PubMed Web of Science ®Google Scholar
• Park TS, Lee JS, Seo JB, et al. Study design and outcomes of Korean Obstructive Lung Disease (KOLD) cohort study. Tuberc Respir Dis (Seoul). 2014;76(4):169–174. doi:10.4046/trd.2014.76.4.16924851130
   PubMedGoogle Scholar
• Kim WJ, Oh Y-M, Sung J, et al. Lung function response to 12-week treatment with combined inhalation of long-acting β2 agonist and glucocorticoid according to ADRB2 polymorphism in patients with chronic obstructive pulmonary disease. Lung. 2008;186(6):381–386. doi:10.1007/s00408-008-9103-918758858
   PubMed Web of Science ®Google Scholar
• Crapo RO, Hankinson JL, Irvin C, et al. Standardization of spirometry: 1994 update. Am J Respir Crit Care Med. 1995;152(3):1107–1136. doi:10.1164/ajrccm.152.3.76637927663792
   PubMed Web of Science ®Google Scholar
• Kim J, Yoon HI, Oh YM, et al. Lung function decline rates according to GOLD group in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2015;10:1819–1827.26379432
   PubMed Web of Science ®Google Scholar
• Martinez FJ, Abrahams RA, Ferguson GT, et al. Effects of baseline symptom burden on treatment response in COPD. Int J Chron Obstruct Pulmon Dis. 2019;14:181–194. doi:10.2147/COPD.S17991230655665
   PubMed Web of Science ®Google Scholar
• Hurst J, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363:1128–1138. doi:10.1056/NEJMoa090988320843247
   PubMed Web of Science ®Google Scholar
• Boulet LP, Boulay ME, Milot J, Lepage J, Bilodeau L, Maltais F. Longitudinal comparison of outcomes in patients with smoking-related asthma-COPD overlap and in non-smoking asthmatics with incomplete reversibility of airway obstruction. Int J Chron Obstruct Pulmon Dis. 2019;14:493–498. doi:10.2147/COPD.S19200330880939
   PubMed Web of Science ®Google Scholar
• Müllerová H, Meeraus WH, Galkin DV, Albers FC, Landis SH. Clinical burden of illness among patients with severe eosinophilic COPD. Int J Chron Obstruct Pulmon Dis. 2019;14:741–755. doi:10.2147/COPD.S19451131114180
   PubMed Web of Science ®Google Scholar
• Kania A, Krenke R, Kuziemski K, et al. Distribution and characteristics of COPD phenotypes - results from the Polish sub-cohort of the POPE study. Int J Chron Obstruct Pulmon Dis. 2018;13:1613–1621.29844667
   PubMed Web of Science ®Google Scholar
• Seemungal TA, Donaldson GC, Bhowmik A, Jeffries DJ, Wedzicha JA. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;161(5):1608–1613. doi:10.1164/ajrccm.161.5.990802210806163
   PubMed Web of Science ®Google Scholar
• Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157(5):1418–1422. doi:10.1164/ajrccm.157.5.97090329603117
   PubMed Web of Science ®Google Scholar
• Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581–586. doi:10.1136/thx.54.7.58110377201
   PubMed Web of Science ®Google Scholar
• Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest. 2002;121(5):1434–1440. doi:10.1378/chest.121.5.143412006425
   PubMed Web of Science ®Google Scholar
• Hwang YI, Park YB, Yoon HK, et al. Male current smokers have low awareness and optimistic bias about COPD: field survey results about COPD in Korea. Int J Chron Obstruct Pulmon Dis. 2019;14:271–277. doi:10.2147/COPD.S18985930718953
   PubMed Web of Science ®Google Scholar